Literature DB >> 11168639

Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.

J Kovarik1, P Bozzotti, C Tougne, H L Davis, P H Lambert, A M Krieg, C A Siegrist.   

Abstract

Oligodeoxynucleotides containing CpG motifs (CpG-ODN) are potent in vitro B-cell activators and they have been successfully used to increase in vivo antibody responses to T-dependent peptide and protein antigens. In contrast, the use of CpG-ODN to enhance in vivo antibody responses to various T-independent type 2 (TI-2) antigens has recently generated contradictory results. In this study, we compared the CpG-ODN stimulatory effect on antibody responses of adult and young BALB/c mice to trinitrophenylaminoethyl-carboxymethyl (TNP) -Ficoll and to polysaccharides (PS) from several distinct serotypes of Streptococcus pneumoniae (SPn). CpG-ODN co-administration significantly enhanced antigen-specific immunoglobulin M (IgM), IgG, IgG1 and IgG2a titres to TNP-Ficoll. The depletion of CD4+ cells by monoclonal antibodies (GK1.5) identified their essential role in CpG-ODN-mediated enhancement of antibody responses. In contrast to TNP-Ficoll, CpG-ODN failed to enhance IgM and IgG responses to any of the 18 SPnPS serotypes tested. Providing T-cell epitopes by the conjugation of SPnPS to the carrier protein tetanus toxoid again allowed CpG-ODN to mediate enhancement of IgG, IgG2a and IgG3 responses to most SPnPS serotypes. Thus, antigen-presenting cell/T-cell interaction appears to largely mediate the in vivo influence of CpG-ODN on antibody responses to TI-2 antigens. In early life, additional factors limit CpG-ODN modulation of antibody responses to TI-2 antigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168639      PMCID: PMC1783157          DOI: 10.1046/j.1365-2567.2001.01158.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  CpG oligodeoxynucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymus-independent stimuli anti-IgM and TNP-Ficoll.

Authors:  R L Chelvarajan; R Raithatha; C Venkataraman; R Kaul; S S Han; D A Robertson; S Bondada
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

2.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

Authors:  M Roman; E Martin-Orozco; J S Goodman; M D Nguyen; Y Sato; A Ronaghy; R S Kornbluth; D D Richman; D A Carson; E Raz
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

Review 3.  The consequences of the intracellular retention of pathogen-derived T-cell-independent antigens on protein presentation to T cells.

Authors:  F Leyva-Cobián; I M Outschoorn; E Carrasco-Marín; C Alvarez-Domínguez
Journal:  Clin Immunol Immunopathol       Date:  1997-10

4.  CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.

Authors:  G B Lipford; M Bauer; C Blank; R Reiter; H Wagner; K Heeg
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

5.  Restoration of T cell-independent type 2 induction of Ig secretion by neonatal B cells in vitro.

Authors:  C M Snapper; F R Rosas; M A Moorman; J J Mond
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

6.  Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting.

Authors:  C Barrios; P Brawand; M Berney; C Brandt; P H Lambert; C A Siegrist
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

7.  Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.

Authors:  G J Weiner; H M Liu; J E Wooldridge; C E Dahle; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.

Authors:  M González-Fernández; E Carrasco-Marín; C Alvarez-Domínguez; I M Outschoorn; F Leyva-Cobián
Journal:  Cell Immunol       Date:  1997-02-25       Impact factor: 4.868

9.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

10.  CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.

Authors:  R S Chu; O S Targoni; A M Krieg; P V Lehmann; C V Harding
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  11 in total

Review 1.  The role of B cells and accessory cells in the neonatal response to TI-2 antigens.

Authors:  Cheri D Landers; R Lakshman Chelvarajan; Subbarao Bondada
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice.

Authors:  Katrine M Jensen; Jesper Melchjorsen; Frederik Dagnaes-Hansen; Uffe B S Sørensen; Rune R Laursen; Lars Østergaard; Ole S Søgaard; Martin Tolstrup
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

3.  DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.

Authors:  Preeti Pancholi; Marion Perkus; Nancy Tricoche; Qingyan Liu; Alfred M Prince
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism.

Authors:  Jerome T McKay; Ryan P Egan; Rama D Yammani; Lieping Chen; Tahiro Shin; Hideo Yagita; Karen M Haas
Journal:  J Immunol       Date:  2015-01-26       Impact factor: 5.422

5.  CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.

Authors:  Matthew P Bernard; Richard P Phipps
Journal:  Clin Immunol       Date:  2007-08-28       Impact factor: 3.969

6.  Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.

Authors:  Goutam Sen; Quanyi Chen; Clifford M Snapper
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

7.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

Review 8.  B-cell responses to vaccination at the extremes of age.

Authors:  Claire-Anne Siegrist; Richard Aspinall
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

9.  Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.

Authors:  Cynthia Calzas; Morgan Taillardet; Insaf Salem Fourati; David Roy; Marcelo Gottschalk; Hugo Soudeyns; Thierry Defrance; Mariela Segura
Journal:  Pathogens       Date:  2017-04-20

10.  Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.

Authors:  Arun T Kamath; Anne-Françoise Rochat; Mario P Valenti; Else Marie Agger; Karen Lingnau; Peter Andersen; Paul-Henri Lambert; Claire-Anne Siegrist
Journal:  PLoS One       Date:  2008-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.